Bone Biologics Corp (BBLG)

Name: Bone Biologics Corp (BBLG) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Bone Biologics Corp (BBLG)

Stock Card

$0.58

$-0.04 (-6.18%)

As on 31-Aug-2026 16:00EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Bone Biologics Corp (BBLG) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.56 High: 0.59

52 Week Range

Low: 0.56 High: 2.89

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.5 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

0.1
Debt to Equity

0
Book Value

$--
EPS

$-1.8
Face value

--
Shares outstanding

2,756,057

10 Years Aggregate

CFO

$-39.09 Mln

EBITDA

$-55.77 Mln

Net Profit

$-65.93 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Bone Biologics Corp (BBLG)	-60.2	-32.9	-56.3	-73.2	-73.8	--	-60.2
BSE Sensex	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
Bone Biologics Corp (BBLG)	-74.3	-78.9	-91.0	-94.0
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Bone Biologics Corp (BBLG)	0.6	1.7	0.0	-2.9	--	-62.2	--	0.4
10X Genomics Inc (TXG)	62.5	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	58.0	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	179.1	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	101.0	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Merit Medical Systems (MMSI)	90.7	5,403.2	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	323.2	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	181.0	9,947.9	785.1	41.5	9.9	2	251.8	4.9

Shareholding Pattern

View Details

About Bone Biologics Corp (BBLG)

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which... provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. Read more

CEO & President

Mr. Jeffrey Frelick
CEO & President

Mr. Jeffrey Frelick
Headquarters

Burlington, MA
Website

https://www.bonebiologics.com

FAQs for Bone Biologics Corp (BBLG)

What is the current share price of Bone Biologics Corp (BBLG) Today?

The share price of Bone Biologics Corp (BBLG) is $0.58 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Bone Biologics Corp (BBLG) has given a return of -73.81% in the last 3 years.

What is the current PB & PE ratio of Bone Biologics Corp (BBLG)?

Since, TTM earnings of Bone Biologics Corp (BBLG) is negative, P/E ratio is not available.
The P/B ratio of Bone Biologics Corp (BBLG) is 0.43 times as on 28-Aug-2026, a 89 discount to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.55	0.32
2024	-0.68	0.80
2023	-0.23	0.71
2022	-0.01	0.00
2021	-0.09	0.02

What is the 52 Week High and Low of Bone Biologics Corp (BBLG)?

The 52-week high and low of Bone Biologics Corp (BBLG) are Rs 2.89 and Rs 0.56 as of 01-Sep-2026.

What is the market cap of Bone Biologics Corp (BBLG)?

Bone Biologics Corp (BBLG) has a market capitalisation of $ 2 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Bone Biologics Corp (BBLG)?

Before investing in Bone Biologics Corp (BBLG), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.